115 related articles for article (PubMed ID: 8464036)
1. Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction.
Yamamoto Y; Kamiya K; Terao S
J Med Chem; 1993 Apr; 36(7):820-5. PubMed ID: 8464036
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of cysteinyl and serine residues of human thromboxane A2 receptor in insect cells.
Chiang N; Kan WM; Tai HH
Arch Biochem Biophys; 1996 Oct; 334(1):9-17. PubMed ID: 8837733
[TBL] [Abstract][Full Text] [Related]
3. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder.
Hirata T; Kakizuka A; Ushikubi F; Fuse I; Okuma M; Narumiya S
J Clin Invest; 1994 Oct; 94(4):1662-7. PubMed ID: 7929844
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of an endogenous COS-7 cell thromboxane A2 receptor.
Becker KP; Ullian M; Halushka PV
Biochim Biophys Acta; 1998 May; 1403(1):109-14. PubMed ID: 9622606
[TBL] [Abstract][Full Text] [Related]
5. A strategy using NMR peptide structures of thromboxane A2 receptor as templates to construct ligand-recognition pocket of prostacyclin receptor.
Ruan CH; Wu J; Ruan KH
BMC Biochem; 2005 Nov; 6():23. PubMed ID: 16271145
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of a dominantly inherited bleeding disorder with impaired platelet responses to thromboxane A2.
Okuma M; Hirata T; Ushikubi F; Kakizuka A; Narumiya S
Pol J Pharmacol; 1996; 48(1):77-82. PubMed ID: 9112632
[TBL] [Abstract][Full Text] [Related]
7. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
[TBL] [Abstract][Full Text] [Related]
8. Anti-peptide antibodies against the human blood platelet thromboxane A2/prostaglandin H2 receptor. Production, purification and characterization.
Borg C; Lam SC; Dieter JP; Lim CT; Komiotis D; Venton DL; Le Breton GC
Biochem Pharmacol; 1993 May; 45(10):2071-8. PubMed ID: 7685602
[TBL] [Abstract][Full Text] [Related]
9. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
Hanasaki K; Arita H
Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
[TBL] [Abstract][Full Text] [Related]
10. Mapping of a ligand-binding site for the human thromboxane A2 receptor protein.
Turek JW; Halmos T; Sullivan NL; Antonakis K; Le Breton GC
J Biol Chem; 2002 May; 277(19):16791-7. PubMed ID: 11877412
[TBL] [Abstract][Full Text] [Related]
11. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
12. The C-terminus of the thromboxane receptor contributes to coupling and desensitization in a mouse mesangial cell line.
Spurney RF; Coffman TM
J Pharmacol Exp Ther; 1997 Oct; 283(1):207-15. PubMed ID: 9336326
[TBL] [Abstract][Full Text] [Related]
13. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
Mais DE; Kochel PJ; Saussy DL; Halushka PV
Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of the second extracellular loop of human thromboxane A2 receptor.
Ruan KH; So SP; Wu J; Li D; Huang A; Kung J
Biochemistry; 2001 Jan; 40(1):275-80. PubMed ID: 11141080
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of the TXA2 receptor by seratrodast: a structural approach.
Wouters J; Durant F; Masereel B
Bioorg Med Chem Lett; 1999 Oct; 9(19):2867-70. PubMed ID: 10522708
[TBL] [Abstract][Full Text] [Related]
16. Changes in glomerular thromboxane A2 receptor expression and ligand binding following immune injury.
Bresnahan BA; Dufek S; Wu S; Lianos EA
Kidney Int; 1999 Jan; 55(1):139-47. PubMed ID: 9893122
[TBL] [Abstract][Full Text] [Related]
17. Refined pharmacophore features for virtual screening of human thromboxane A2 receptor antagonists.
Hu B; Joseph J; Geng X; Wu Y; Suleiman MR; Liu X; Shi J; Wang X; He Z; Wang J; Cheng M
Comput Biol Chem; 2020 Jun; 86():107249. PubMed ID: 32199335
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F
Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517
[TBL] [Abstract][Full Text] [Related]
19. Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors.
Halushka PV; Mais DE; Saussy DL
Fed Proc; 1987 Jan; 46(1):149-53. PubMed ID: 2948839
[TBL] [Abstract][Full Text] [Related]
20. Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation.
Hirata T; Ushikubi F; Kakizuka A; Okuma M; Narumiya S
J Clin Invest; 1996 Feb; 97(4):949-56. PubMed ID: 8613548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
